2-[2-(2,6-dioxopiperidin-3-yl)-7-hydroxyisoindol-1-yl]-2-oxoacetaldehyde
C15H12N2O5 — CID 174984156
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[2-(2,6-dioxopiperidin-3-yl)-7-hydroxyisoindol-1-yl]-2-oxoacetaldehyde
2-[2-(2,6-dioxopiperidin-3-yl)-7-hydroxyisoindol-1-yl]-2-oxoacetaldehyde (PubChem CID 174984156) has the molecular formula C15H12N2O5 and a molecular weight of 300.27 g/mol. Its IUPAC name is 2-[2-(2,6-dioxopiperidin-3-yl)-7-hydroxyisoindol-1-yl]-2-oxoacetaldehyde.
Molecular Properties
| Compound Name | 2-[2-(2,6-dioxopiperidin-3-yl)-7-hydroxyisoindol-1-yl]-2-oxoacetaldehyde |
|---|---|
| PubChem CID | 174984156 |
| Molecular Formula | C15H12N2O5 |
| Molecular Weight | 300.27 g/mol |
| Exact Mass | 300.07 |
| IUPAC Name | 2-[2-(2,6-dioxopiperidin-3-yl)-7-hydroxyisoindol-1-yl]-2-oxoacetaldehyde |
| SMILES | O=CC(=O)c1c2c(O)cccc2cn1C1CCC(=O)NC1=O |
| InChI | InChI=1S/C15H12N2O5/c18-7-11(20)14-13-8(2-1-3-10(13)19)6-17(14)9-4-5-12(21)16-15(9)22/h1-3,6-7,9,19H,4-5H2,(H,16,21,22) |
| InChIKey | LNFUHSRMRUYIPD-UHFFFAOYSA-N |
| XLogP | 0.71 |
| TPSA | 105.47 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 22 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 300.27 |
| LogP ≤ 5 | 0.71 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'diketo_group', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 174984156 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.